Last reviewed · How we verify
Preventive treatment of episodic migraine
Approved treatments
Pipeline
- Rimegepant 75 MG · Pfizer Inc. — Phase 4
Clinical guidelines
- FDA label — 1L
NURTEC ODT is indicated for the preventive treatment of episodic migraine in adults. - FDA label — 1L
NURTEC ODT is indicated for the preventive treatment of episodic migraine in adults.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Preventive treatment of episodic migraine patent landscape — cliff calendar, originator estates, attackable patents
- Preventive treatment of episodic migraine treatment landscape brief
- Preventive treatment of episodic migraine treatment updates RSS
Frequently asked questions about Preventive treatment of episodic migraine
What new drugs are in development for Preventive treatment of episodic migraine?
1 pipeline drugs tracked. Top candidates: Rimegepant 75 MG.
What are the treatment guidelines for Preventive treatment of episodic migraine?
FDA label publishes guidelines for Preventive treatment of episodic migraine. 2 guideline references tracked.
Related
- Treatment landscape: Preventive treatment of episodic migraine patent cliff · Preventive treatment of episodic migraine CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing